Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 23, Issue 6 , Pages 751-764 , December 2009

Pathological assessment of intrauterine growth restriction

  • Phillip Cox, MBBS, PhD, FRCPath (Consultant Perinatal Pathologist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1216272729; Fax: +44 1216074721.
    • ,
  • Tamas Marton, MD, PhD (Consultant Perinatal Pathologist)

References 

  1. Gardosi J. Fetal growth: towards an international standard. Ultrasound Obstet Gynecol. 2005 Aug;26(2):112–114
  2. Wigglesworth JS. Monitoring perinatal mortality. A pathophysiological approach. Lancet. 1980 Sep 27;2(8196):684–686
  3. Consortium. MaCH. CESDI 8th annual report: Confidential Enquiry of Stillbirths and Deaths in Infancy. London; 2001 Contract No.: Document Number|.
  4. Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol. 2004 Aug;191(2):481–487
  5. de Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. Aust N Z J Obstet Gynaecol. 2006 Feb;46(1):4–14
  6. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006 Jun;49(2):270–283
  7. Eriksson JG. Epidemiology, genes and the environment: lessons learned from the Helsinki Birth Cohort Study. J Intern Med. 2007 May;261(5):418–425
  8. Mayhew TM. Allometric studies on growth and development of the human placenta: growth of tissue compartments and diffusive conductances in relation to placental volume and fetal mass. J Anat. 2006 Jun;208(6):785–794
  9. Mitchell MC, Lerner E. Weight gain and pregnancy outcome in underweight and normal weight women. J Am Diet Assoc. 1989 May;89(5):634–63841
  10. Gardosi J, Mul T, Mongelli M, et al. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol. 1998 May;105(5):524–530
  11. Froen JF, Gardosi JO, Thurmann A, et al. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand. 2004 Sep;83(9):801–807
  12. Gardosi J. Customized growth curves. Clin Obstet Gynecol. 1997 Dec;40(4):715–722
  13. Figueras F, Figueras J, Meler E, et al. Customized birthweight standards accurately predict perinatal morbidity. Arch Dis Child Fetal Neonatal Ed. 2007 Jan 24;
  14. Maroun LL, Graem N. Autopsy standards of body parameters and fresh organ weights in nonmacerated and macerated human fetuses. Pediatr Dev Pathol. 2005 Mar–Apr;8(2):204–217
  15. Duncan KR, Issa B, Moore R, et al. A comparison of fetal organ measurements by echo-planar magnetic resonance imaging and ultrasound. BJOG. 2005 Jan;112(1):43–49
  16. Boito S, Struijk PC, Ursem NT, et al. Fetal brain/liver volume ratio and umbilical volume flow parameters relative to normal and abnormal human development. Ultrasound Obstet Gynecol. 2003 Mar;21(3):256–261
  17. Gruenwald P, Minh HN. Evaluation of body and organ weights in perinatal pathology. II. Weight of body and placenta of surviving and of autopsied infants. Am J Obstet Gynecol. 1961 Aug;82:312–319
  18. Mitchell ML. Fetal brain to liver weight ratio as a measure of intrauterine growth retardation: analysis of 182 stillborn autopsies. Mod Pathol. 2001 Jan;14(1):14–19
  19. Becker MJ, Becker AE. Fat distribution in the adrenal cortex as an indication of the mode of intrauterine death. Hum Pathol. 1976 Sep;7(5):495–504
  20. Hendrix N, Berghella V. Non-placental causes of intrauterine growth restriction. Semin Perinatol. 2008 Jun;32(3):161–165
  21. Choong CS, Patole S, Whitehall J. Congenital varicella syndrome in the absence of cutaneous lesions. J Paediatr Child Health. 2000 Apr;36(2):184–185
  22. Schuster V, Janssen W, Seidenspinner S, et al. [Congenital Epstein-Barr virus infection], Monatsschr Kinderheilkd. 1993 May;141(5):401–404
  23. Kobayashi K, Tajima M, Toishi S, et al. Fetal growth restriction associated with measles virus infection during pregnancy. J Perinat Med. 2005;33(1):67–68
  24. Iroha EO, Ezeaka VC, Akinsulie AO, et al. Maternal HIV infection and intrauterine growth: a prospective study in Lagos, Nigeria. West Afr J Med. 2007 Apr–Jun;26(2):121–125
  25. Temmerman M, Chomba EN, Ndinya-Achola J, et al. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol. 1994 Apr;83(4):495–501
  26. Kaplan C. The placenta and viral infections. Semin Diagn Pathol. 1993 Aug;10(3):232–250
  27. Popek EJ. Granulomatous villitis due to Toxoplasma gondii. Pediatr Pathol. 1992 Mar–Apr;12(2):281–288
  28. Bjoro K. Gross pathology of the placenta in intrauterine growth retardation. Ann Chir Gynaecol. 1981;70(6):316–322
  29. Bjoro K. Vascular anomalies of the umbilical cord: I. Obstetric implications. Early Hum Dev. 1983 Jul;8(2):119–127
  30. de Laat MW, Franx A, van Alderen ED, et al. The umbilical coiling index, a review of the literature. J Matern Fetal Neonatal Med. 2005 Feb;17(2):93–100
  31. Kaplan CG. Fetal and maternal vascular lesions. Semin Diagn Pathol. 2007 Feb;24(1):14–22
  32. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995 Jan;26(1):80–85
  33. Leistra-Leistra MJ, Timmer A, van Spronsen FJ, et al. Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?. Placenta. 2004 Apr;25(Suppl. A):S102–S105
  34. Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol. 2004 Dec;35(12):1494–1498
  35. Baergen RN. Miscellaneous placental lesions. Manual of Benirschke and Kaufmann's Pathology of the Human Placenta. New York: Springer; 2005;p. 360–1
  36. Parveen Z, Tongson-Ignacio JE, Fraser CR, et al. Placental mesenchymal dysplasia. Arch Pathol Lab Med. 2007 Jan;131(1):131–137
  37. Pham T, Steele J, Stayboldt C, et al. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature. Am J Clin Pathol. 2006 Jul;126(1):67–78
  38. Robinson WP, Lauzon JL, Innes AM, et al. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod. 2007 Apr;22(4):1114–1122
  39. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007 Oct;38(10):1439–1446
  40. Weber MA, Nikkels PG, Hamoen K, et al. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report. Pediatr Dev Pathol. 2006 May–Jun;9(3):234–238
  41. Boyd TK, Redline RW. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum Pathol. 2000 Nov;31(11):1389–1396
  42. Hung NA, Jackson C, Nicholson M, et al. Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: are they pathogenetically related?. Arthritis Rheum. 2006 Feb 15;55(1):154–156
  43. Sebire NJ, Backos M, Goldin RD, et al. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG. 2002 May;109(5):570–573
  44. Makino A, Suzuki Y, Yamamoto T, et al. Use of aspirin and low-molecular-weight heparin to prevent recurrence of maternal floor infarction in women without evidence of antiphospholipid antibody syndrome. Fetal Diagn Ther. 2004 May–Jun;19(3):261–265
  45. Boog G, Le Vaillant C, Alnoukari F, et al. [Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology], J Gynecol Obstet Biol Reprod (Paris). 2006 Jun;35(4):396–404
  46. Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):9–15
  47. Kingdom J, Huppertz B, Seaward G, et al. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 2000 Sep;92(1):35–43
  48. Salafia CM. Placental pathology of fetal growth restriction. Clin Obstet Gynecol. 1997 Dec;40(4):740–749
  49. Tyson RW, Staat BC. The intrauterine growth-restricted fetus and placenta evaluation. Semin Perinatol. 2008 Jun;32(3):166–171
  50. Roberts DJ, Post MD. The placenta in preeclampsia and IUGR. J Clin Pathol. 2008 Jul 19;
  51. Ogishima D, Matsumoto T, Nakamura Y, et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int. 2000 Mar;50(3):224–229
  52. Redline RW. Thrombophilia and placental pathology. Clin Obstet Gynecol. 2006 Dec;49(4):885–894

PII: S1521-6934(09)00082-0

doi: 10.1016/j.bpobgyn.2009.06.006

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 23, Issue 6 , Pages 751-764 , December 2009

Article Tools

* Image Usage & Resolution